As a new SIRPα-Fc fusion protein targeting the CD47/SIRPα pathway, IMM01 exhibited strong dual-functional anti-tumor activity through phagocytosis by blocking the “do not eat me” signal and activating the “eat me” signal. This evidence concerns the gene CD47 and neoplasm.